TAVR Academy III: Today's New Frontiers

Tuesday, May 21, 2019: 1:45 PM-3:15 PM

Nolita Ballroom 2 (The Cosmopolitan of Las Vegas)

Moderators:

Philippe Genereux MD, M.D. and Chandan Devireddy, M.D., FSCAI

Panelists:

William M. Suh, M.D. , Hasan Jilaihawi, M.D. , Adnan K. Chhatriwalla, M.D., FSCAI , Robert C. Stoler, M.D., FSCAI and Scott M. Lilly, M.D., Ph.D.

1:45 PM

Minimalist Strategies: Lean or Extreme?
Jay S. Giri, M.D., Hospital of the University of Pennsylvania

1:55 PM

Pro: Every TAVR Should Receive Cerebral Embolic Protection!
Amar Krishnaswamy, M.D., Cleveland Clinic

2:05 PM

Con: Cerebral Embolic Protection is a Niche Concept
John K. Forrest, M.D., FSCAI, Yale School of medicine

2:15 PM

Discussion

2:25 PM

Antithrombotic Strategies Post-TAVR
Amit N. Vora, M.D., Pinnacle Health Cardiovascular Institute

2:35 PM

VIV TAVR: Key Aspects of Patient Selection and Procedural Planning
Danny Dvir, M.D., University of Washington Medical Center

2:45 PM

Bioprosthetic Valve Fracture: Current Techniques and Controversies
Adnan K. Chhatriwalla, M.D., FSCAI, Saint Luke's Mid America Heart Institute

2:55 PM

An Ounce of Prevention: BASILICA to Prevent Coronary Obstruction
Jaffar Khan, M.D., NIH/NHLBI

3:05 PM

Discussion